Diagnosis of Guillain-Barré Syndrome
Diagnosis of Guillain-Barré Syndrome The diagnosis of Guillain-Barré Syndrome is primarily clinical, based on a careful assessment of symptoms, history, and neurological examination. As no single test definitively confirms the diagnosis of Guillain-Barré Syndrome, doctors rely on a combination of physical findings, electrodiagnostic tests, and supportive laboratory evidence. Given the potential severity of GBS and its rapid progression, prompt and accurate diagnosis is crucial. Early recognition allows for immediate treatment, reducing the risk of complications such as respiratory failure or permanent nerve damage. Clinical Evaluation The diagnostic process begins with a detailed medical history and neurological examination. Doctors will ask about: Recent infections, particularly gastrointestinal or respiratory illnesses Vaccinations or surgery within the past few weeks Onset and progression of weakness Sensory symptoms, such as tingling or numbness Reflex changes and mobility difficulties Key clinical signs pointing toward GBS include: Symmetric, ascending muscle weakness Reduced or absent reflexes (areflexia) No fever at onset of neurological symptoms Rapid progression (hours to days) The presence of these features usually raises strong suspicion for GBS and warrants urgent testing. Diagnostic Criteria The most widely accepted diagnostic framework is from the National Institute of Neurological Disorders and Stroke (NINDS). Essential criteria include: Progressive weakness in more than one limb Areflexia (loss of tendon reflexes) Progression over hours to 4 weeks Symmetry of symptoms Exclusion of other causes Supportive findings may include: Facial or cranial nerve involvement Mild sensory symptoms Autonomic dysfunction Lumbar Puncture (Spinal Tap) A lumbar puncture helps confirm the diagnosis by analysing cerebrospinal fluid (CSF). In GBS: CSF shows elevated protein levels White blood cell count is normal or very low This is known as albuminocytologic dissociation It may take several days for protein levels to rise, so a normal early result does not rule out GBS. Nerve Conduction Studies and Electromyography (EMG) These tests measure how well electrical signals move through nerves and muscles: In GBS, conduction velocity is slowed, reflecting demyelination EMG shows reduced muscle activity Abnormalities confirm nerve dysfunction and help identify the GBS subtype These tests are highly valuable but may be less useful in the earliest stages of the illness. Blood Tests and Imaging Blood tests are not specific for GBS but are used to: Exclude infections, metabolic disorders, or autoimmune conditions Check inflammatory markers, electrolytes, and vitamin levels Imaging (such as MRI) may be done to: Rule out spinal cord compression, tumours, or other structural issues Assess inflammation in spinal nerve roots (seen as enhancement on MRI) These tools help eliminate alternative explanations for neurological symptoms. Antibody Testing In specific cases, especially with Miller Fisher Syndrome, antibody tests may detect: Anti-GQ1b antibodies, linked to eye muscle paralysis and ataxia Other antiganglioside antibodies, such as anti-GM1, GD1a, or GT1a These tests support the diagnosis but are not required in every case. Differential Diagnosis Conditions that may resemble GBS include: Condition Key Differences Myasthenia gravis Fluctuating weakness, no sensory symptoms, normal reflexes Poliomyelitis Asymmetric weakness, fever present Transverse myelitis Sensory level, bowel/bladder dysfunction, spinal MRI changes Chronic inflammatory demyelinating polyneuropathy (CIDP) Slower progression over 8 weeks or more A thorough assessment ensures that serious alternatives are not missed. Diagnosis in Children Paediatric cases may present differently: More pronounced pain or refusal to walk Irritability or crying when legs are touched May appear clumsy or weak without clear description of symptoms Doctors must rely more on physical exam and parental observation when diagnosing GBS in younger children. Timing and Urgency Because GBS can progress rapidly, clinicians often begin treatment before test results are complete, especially if: The child or adult has progressive weakness Reflexes are lost Breathing or swallowing becomes difficult Starting treatment early improves outcomes and may shorten the duration of hospitalisation. Conclusion | Diagnosis of Guillain-Barré Syndrome Doctors diagnose Guillain-Barré Syndrome by looking for a clear pattern of symptoms—such as sudden weakness, loss of reflexes, and quick worsening over days. In addition, they use tests like a spinal fluid (CSF) analysis and nerve studies to confirm the diagnosis. These tools help doctors start treatment with confidence. Since Guillain-Barré Syndrome can be life-threatening, early diagnosis is crucial. Acting quickly not only improves the chances of recovery but also lowers the risk of long-term disability. [Next: Treatment of Guillain-Barré Syndrome→]









